Early clinical trial reports results in this hidden disease
New Global Head of Cardiovascular and Metabolic Diseases Research looks to apply new tools to address tough challenges.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
For media and journalist inquiries, please contact the Novartis Corporate Media Relations office by email or telephone.
Central Media Line:Phone: +41 61 324 2200
This site is intended for a global audience.